Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 16012992

Capsule imaging.

David Fleischer
View original source ↗Export metadata ↓

Abstract

Capsule endoscopy was conceived in the late 1980s by an electrico-optical engineer and first used in human beings clinically during the last 5 years. Already it has changed the management of small bowel diseases and is beginning to be used in the esophagus. Developments are under way to use the capsule in a wider range of clinical conditions. The literature has advanced from case series to outcome studies. The utility of capsule endoscopy is reviewed here.

Explore related subjects

CapsulesDiagnostic ImagingEndoscopy, GastrointestinalEquipment DesignEquipment SafetyGastrointestinal DiseasesHumansJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

David Fleischer. 2005. Capsule imaging.. https://doi.org/10.1016/s1542-3565(05)00261-2

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride.

A novel oral controlled delivery system for propranolol hydrochloride (PPL) was developed and optimized. The in vitro dissolution profiles of sustained-release matrix tablets of racemic PPL were determined and compared with the United States Pharmacopeia (USP) tolerance specifications for Propranolol Hydrochloride Extended-Release Capsules. The influence of matrix forming agents (native dextran, hydroxypropyl methylcellulose (HPMC), cetyl alcohol) and binary mixtures of them on PPL release in vitro was investigated. A central composite design was applied to the optimization of a sustained-release tablet formulation. The sustained-release matrix tablets with good physical, mechanical and technological properties were obtained with a matrix excipient:PPL ratio of 60:40 (w/w), with a dextran:HPMC ratio of 4:1 (w/w) and with a cetyl alcohol amount of 15% (w/w). A comparative kinetic study of the present matrix tablets and commercial SUMIAL RETARD capsules (Spain) was established. The value for the similarity factor (f(2)=69.6) suggested that the dissolution profile of the present two sustained-release oral dosage forms are similar. Higuchi (diffusion) and Hixon-Crowell (erosion) kinetic profiles were achieved and this codependent mechanism of drug release was established.

Capsules↗
PubMed2006

Microfluidics assisted synthesis of well-defined spherical polymeric microcapsules and their utilization as potential encapsulants.

In this article, the development of a novel technique to fabricate spherical polymeric microcapsules by utilizing microfluidic technology is presented. Atom transfer radical polymerization (ATRP) was employed to synthesize well-defined amphiphilic block copolymers. An organic polymer solution was constrained to adopt the spherical droplets in a continuous water phase at a T-junction microchannel, and the generation of the droplets was studied quantitatively. The flow conditions of two immiscible solutions were adjusted for the successful generation of the polymer droplets. The morphology of the microcapsules was examined. The efficiency of these polymer microcapsules as containers for the storage and controlled release of loaded molecules was evaluated by encapsulating the microcapsules with Congo-red dye and investigating the release performance using temperature controlled UV-VIS spectroscopy.

Capsules↗